Designing modulators of 5-hydroxytryptamine signaling to treat abuse disorders

Bibliography

• Zhang XY, Kosten TA. Prazosin an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. Biol Psychiatry 2005;57(10):1202-4
   PubMed Web of Science ®Google Scholar
• Kozikowski AP, Araldi GL, Prakash KR, et al. Synthesis and biological properties of new 2beta-alkyl- and 2beta-aryl-3-(substituted phenyl)tropane derivatives: stereochemical effect of C-3 on affinity and selectivity for neuronal dopamine and serotonin transporters. J Med Chem 1998;41(25):4973-82
   PubMed Web of Science ®Google Scholar
• Ritz MC, Lamb R, Kuhar M. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987;237(4819):1219-23
   PubMed Web of Science ®Google Scholar
• Verheij MM, de Mulder EL, De Leonibus E, et al. Rats that differentially respond to cocaine differ in their dopaminergic storage capacity of the nucleus accumbens. J Neurochem 2008;105(6):2122-33
   PubMed Web of Science ®Google Scholar
• Verheij MM, Karel PA, Cools R, et al. Reduced cocaine-induced serotonin, but not dopamine and noradrenaline, release in rats with a genetic deletion of serotonin transporters. Eur Neuropsychopharmacol 2014; In press
   PubMed Web of Science ®Google Scholar
• Ahmed S, Koob G. Transition from moderate to excessive drug intake: change in hedonic set point. Science 1998;282(5387):298-300
   PubMed Web of Science ®Google Scholar
• Pomara C, Cassano T, D’Errico S, et al. Data available on the extent of cocaine use and dependence: biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. Curr Med Chem 2012;19(33):5647-57
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Kosten TR. Novel approaches to the treatment of cocaine addiction. CNS Drugs 2005;19(1):13-25
   PubMed Web of Science ®Google Scholar
• Johanson C, Fischman MW. The pharmacology of cocaine related to its abuse. Pharmacol Rev 1989;41(1):3-52
   PubMed Web of Science ®Google Scholar
• Sardão VA, Pereira SL, Oliveira PJ. Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury. Expert Opin Drug Saf 2008;7(2):129-46
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379(9810):55-70
   PubMed Web of Science ®Google Scholar
• Kim JH, Lawrence AJ. Drugs currently in Phase. II clinical trials for cocaine addiction. Expert Opin Investig Drugs 2014;23(8):1105-22
   PubMed Web of Science ®Google Scholar
• Nonkes LJ, Van Bussel IP, Verheij MM, et al. The interplay between brain 5-hydroxytryptamine levels and cocaine addiction. Behav Pharmacol 2011;22(8):723-38
   PubMed Web of Science ®Google Scholar
• Fitzgerald PJ. Elevated norepinephrine may be a unifying etiological Factor in the Abuse of a Broad Range of substances: alcohol, nicotine, Marijuana, Heroin, cocaine, and caffeine. Subst abuse 2013;7:171
   PubMedGoogle Scholar
• Caffino L, Calabrese F, Giannotti G, et al. Stress rapidly dysregulates the glutamatergic synapse in the prefrontal cortex of cocaine-withdrawn adolescent rats. Addict Biol 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Filip M, Frankowska M, Sadakierska-Chudy A, et al. GABAB receptors as a therapeutic strategy in substance use disorders: Focus on positive allosteric modulators. Neuropharmacology 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Haile CN, Mahoney JJ III, Newton TF, et al. Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther 2012;134(2):260-77
   PubMed Web of Science ®Google Scholar
• Mitrano DA, Schroeder JP, Smith Y, et al. Alpha-1 adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology 2012;37(9):2161-72
   PubMed Web of Science ®Google Scholar
• Verheij MM, Saigusa T, Koshikawa N, et al. Working Mechanism Underlying the Reduction of the Behavioral and Accumbal Dopamine Response to Cocaine by alpha-1-Adrenoceptor Antagonists. Neuropsychopharmacology 2013;38(3):540
   PubMed Web of Science ®Google Scholar
• Karila L, Gorelick D, Weinstein A, et al. New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol 2008;11(3):425-38
   PubMed Web of Science ®Google Scholar
• Carrera MRA, Ashley JA, Zhou B, et al. Cocaine vaccines: antibody protection against relapse in a rat model. Proc Natl Acad Sci USA 2000;97(11):6202-6
   PubMed Web of Science ®Google Scholar
• Rocha BA, Fumagalli F, Gainetdinov RR, et al. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1998;1(2):132-7
   PubMed Web of Science ®Google Scholar
• Calabrese F, Doelen R, Guidotti G, et al. Exposure to early life stress regulates Bdnf expression in SERT mutant rats in an anatomically-selective fashion. J Neurochem 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Calabrese F, Guidotti G, Middelman A, et al. Lack of serotonin transporter alters bdnf expression in the rat brain during early postnatal development. Mol Neurobiol 2013;48(1):244-56
   PubMed Web of Science ®Google Scholar
• Müller CP, Homberg JR. The role of serotonin in drug use and addiction. Behav Brain Res 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Deroche-Gamonet V, Belin D, Piazza PV. Evidence for addiction-like behavior in the rat. Science 2004;305(5686):1014-17
   PubMed Web of Science ®Google Scholar
• Paterson NE, Markou A. Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 2003;14(17):2229-32
   PubMed Web of Science ®Google Scholar
• Zorrilla EP, Wee S, Zhao Y, et al. Extended access cocaine self‐administration differentially activates dorsal raphe and amygdala corticotropin‐releasing factor systems in rats. Addiction biology 2012;17(2):300-8
   PubMed Web of Science ®Google Scholar
• Huston JP, Silva MA, Topic B, et al. What’s conditioned in conditioned place preference? Trends Pharmacol Sci 2013;34(3):162-6
   PubMed Web of Science ®Google Scholar
• Bardo M, Bevins RA. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 2000;153(1):31-43
   PubMed Web of Science ®Google Scholar
• Bardo MT, Donohew R, Harrington NG. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res 1996;77(1):23-43
   PubMed Web of Science ®Google Scholar
• Naughton M, Mulrooney JB, Leonard BE. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol 2000;15(6):397-415
   PubMed Web of Science ®Google Scholar
• Henry JP, Sagné C, Bedet C, et al. The vesicular monoamine transporter: from chromaffin granule to brain. Neurochem Int 1998;32(3):227-46
   PubMed Web of Science ®Google Scholar
• Best J, Nijhout HF, Reed M. Serotonin synthesis, release and reuptake in terminals: a mathematical model. Theor Biol Med Model 2010;7:34
   PubMed Web of Science ®Google Scholar
• Bockaert J, Claeysen S, Bécamel C, et al. Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res 2006;326(2):553-72
   PubMed Web of Science ®Google Scholar
• Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38(8):1083-152
   PubMed Web of Science ®Google Scholar
• Gerra G, Zaimovic A, Garofano L, et al. Perceived parenting behavior in the childhood of cocaine users: relationship with genotype and personality traits. Am J Med Genet B Neuropsychiatr Genet 2007;144(1):52-7
   Google Scholar
• Homberg J, Olivier J, Smits B, et al. Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 2007;146(4):1662-76
   PubMed Web of Science ®Google Scholar
• Shen HW, Hagino Y, Kobayashi H, et al. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 2004;29(10):1790-9
   PubMed Web of Science ®Google Scholar
• Sora I, Hall FS, Andrews AM, et al. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 2001;98(9):5300-5
   PubMed Web of Science ®Google Scholar
• Homberg JR, De Boer SF, Raasø HS, et al. Adaptations in pre-and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats. Psychopharmacology 2008;200(3):367-80
   PubMed Web of Science ®Google Scholar
• Homberg J, Verheij M, Nonkes L, et al. Serotonin transporter gene variation and compulsive cocaine self-administration in rats. Pogram No. 873.05/V7. Neuroscience Meeting Planner Society for Neuroscience; New Orleans, LA: 2012
   Google Scholar
• Thomsen M, Hall FS, Uhl GR, et al. Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci 2009;29(4):1087-92
   PubMed Web of Science ®Google Scholar
• Sora I, Wichems C, Takahashi N, et al. Cocaine reward models: conditioned place preference can be established in dopamine-and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 1998;95(13):7699-704
   PubMed Web of Science ®Google Scholar
• Hall F, Li X, Sora I, et al. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 2002;115(1):153-61
   PubMed Web of Science ®Google Scholar
• Ansorge MS, Zhou M, Lira A, et al. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004;306(5697):879-81
   PubMed Web of Science ®Google Scholar
• Carroll ME, Lac ST, Asencio M, et al. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 1990;35(1):237-24
   PubMed Web of Science ®Google Scholar
• Bubar M, McMahon L, De Deurwaerdere P, et al. Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. Neuropharmacology 2003;44(3):342-53
   PubMed Web of Science ®Google Scholar
• Parsons LH, Koob GF, Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 1995;274(3):1182-91
   PubMed Web of Science ®Google Scholar
• Tran-Nguyen LT, Baker DA, Grote KA, et al. Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology (Berl) 1999;146(1):60-6
   PubMed Web of Science ®Google Scholar
• Harris GC, Altomare K, Aston-Jones G. Preference for a cocaine-associated environment is attenuated by augmented accumbal serotonin in cocaine withdrawn rats. Psychopharmacology (Berl) 2001;156(1):14-22
   PubMed Web of Science ®Google Scholar
• Hyman C, Hofer M, Barde YA, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991;350(6315):230-2
   PubMed Web of Science ®Google Scholar
• Zhang H, Ozbay F, Lappalainen J, et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer’s disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet 2006;141(4):387-93
   Google Scholar
• Liu QR, Walther D, Drgon T, et al. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson’s Disease. Am J Med Genet B Neuropsychiatr Genet 2005;134(1):93-103
   Google Scholar
• Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007;10(9):1089-93
   PubMed Web of Science ®Google Scholar
• McGinty JF, Whitfield TW Jr, Berglind WJ. Brain-derived neurotrophic factor and cocaine addiction. Brain Res 2010;1314:183-93
   PubMed Web of Science ®Google Scholar
• Mowla SJ, Farhadi HF, Pareek S, et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 2001;276(16):12660-6
   PubMed Web of Science ®Google Scholar
• Pruunsild P, Kazantseva A, Aid T, et al. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007;90(3):397-406
   PubMed Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 2004;126(1):122-3
   Web of Science ®Google Scholar
• Bueller JA, Aftab M, Sen S, et al. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006;59(9):812-15
   PubMed Web of Science ®Google Scholar
• Pezawas L, Verchinski BA, Mattay VS, et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004;24(45):10099-102
   PubMed Web of Science ®Google Scholar
• Hariri AR, Goldberg TE, Mattay VS, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003;23(17):6690-4
   PubMed Web of Science ®Google Scholar
• Conner JM, Lauterborn JC, Yan Q, et al. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 1997;17(7):2295-313
   PubMed Web of Science ®Google Scholar
• Phillips HS, Hains JM, Laramee GR, et al. Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science 1990;250(4978):290-4
   PubMed Web of Science ®Google Scholar
• Angelucci F, Brene S, Mathe A. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005;10(4):345-52
   PubMed Web of Science ®Google Scholar
• von Bartheld CS. Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens. J Neurobiol 2004;58(2):295-314
   PubMedGoogle Scholar
• Atwal JK, Massie B, Miller FD, et al. The TrkB-Shc site signals neuronal survival and local axon growth via MEK and PI3-kinase. Neuron 2000;27(2):265-77
   PubMed Web of Science ®Google Scholar
• West AE, Griffith EC, Greenberg ME. Regulation of transcription factors by neuronal activity. Nat Rev Neurosci 2002;3(12):921-31
   PubMed Web of Science ®Google Scholar
• Nyberg F. Structural plasticity of the brain to psycho-stimulant use. Neuropharmacology 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Rasakham K, Schmidt HD, Kay K, et al. Synapse density and dendritic complexity are reduced in the prefrontal cortex following seven days of forced abstinence from cocaine self-administration. PLoS One 2014;9(7):e102524
   PubMed Web of Science ®Google Scholar
• Schmidt HD, Sangrey GR, Darnell SB, et al. Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem 2012;120(2):202-9
   PubMed Web of Science ®Google Scholar
• Pickens CL, Airavaara M, Theberge F, et al. Neurobiology of the incubation of drug craving. Trends Neurosci 2011;34(8):411-20
   PubMed Web of Science ®Google Scholar
• Grimm JW, Lu L, Hayashi T, et al. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 2003;23(3):742-7
   PubMed Web of Science ®Google Scholar
• Korte M, Carroll P, Wolf E, et al. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1995;92(19):8856-60
   PubMed Web of Science ®Google Scholar
• Sherwood NT, Lo DC. Long-term enhancement of central synaptic transmission by chronic brain-derived neurotrophic factor treatment. J Neurosci 1999;19(16):7025-36
   PubMed Web of Science ®Google Scholar
• Pang PT, Teng HK, Zaitsev E, et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004;306(5695):487-91
   PubMed Web of Science ®Google Scholar
• Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001;2(2):119-28
   PubMed Web of Science ®Google Scholar
• Self DW. Regulation of drug-taking and-seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 2004;47:242-55
   PubMed Web of Science ®Google Scholar
• Le Foll B, Diaz J, Sokoloff P. A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport 2005;16(2):175-8
   PubMed Web of Science ®Google Scholar
• Horger BA, Iyasere CA, Berhow MT, et al. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 1999;19(10):4110-22
   PubMed Web of Science ®Google Scholar
• Filip M, Faron-Górecka A, Kuśmider M, et al. Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res 2006;1071(1):218-25
   PubMed Web of Science ®Google Scholar
• Lu H, Cheng PI, Lim BK, et al. Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition. Neuron 2010;67(5):821-33
   PubMed Web of Science ®Google Scholar
• Fumagalli F, Moro F, Caffino L, et al. Region-specific effects on BDNF expression after contingent or non-contingent cocaine iv self-administration in rats. Int J Neuropsychopharmacol 2013;16(4):913-18
   PubMed Web of Science ®Google Scholar
• Briand L, Lee FS, Blendy JA, et al. Enhanced extinction of cocaine seeking in brain-derived neurotrophic factor Val66Met knock-in mice. Eur J Neurosci 2012;35(6):932-9
   PubMed Web of Science ®Google Scholar
• Hall FS, Drgonova J, Goeb M, et al. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 2003;28(8):1485-90
   PubMed Web of Science ®Google Scholar
• Graham DL, Edwards S, Bachtell RK, et al. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 2007;10(8):1029-37
   PubMed Web of Science ®Google Scholar
• Otis JM, Fitzgerald MK, Mueller D. Infralimbic BDNF/TrkB enhancement of GluN2B currents facilitates extinction of a cocaine-conditioned place preference. J Neurosci 2014;34(17):6057-64
   PubMed Web of Science ®Google Scholar
• Homberg JR, Molteni R, Calabrese F, et al. The serotonin–BDNF duo: developmental implications for the vulnerability to psychopathology. Neurosci Biobehav Rev 2014;43:35-47
   PubMed Web of Science ®Google Scholar
• White LA, Eaton MJ, Castro MC, et al. Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons. J Neurosci 1994;14(11):6744-53
   PubMed Web of Science ®Google Scholar
• Mamounas LA, Blue ME, Siuciak JA, et al. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995;15(12):7929-39
   PubMed Web of Science ®Google Scholar
• Lyons WE, Mamounas LA, Ricaurte GA, et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999;96(26):15239-44
   PubMed Web of Science ®Google Scholar
• Szapacs ME, Mathews TA, Tessarollo L, et al. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. J Neurosci Methods 2004;140(1):81-92
   PubMed Web of Science ®Google Scholar
• Hensler JG, Advani T, Monteggia LM. Regulation of serotonin-1A receptor function in inducible brain-derived neurotrophic factor knockout mice after administration of corticosterone. Biol Psychiatry 2007;62(5):521-9
   PubMed Web of Science ®Google Scholar
• Eaton MJ, Whittemore SR. Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS. Exp Neurol 1996;140(2):105-14
   PubMed Web of Science ®Google Scholar
• Rumajogee P, Vergé D, Hanoun N, et al. Adaption of the serotoninergic neuronal phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP. Eur J Neurosci 2004;19(4):937-44
   PubMed Web of Science ®Google Scholar
• Siuciak JA, Altar A, Wiegand SJ, et al. Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res 1994;633(1):326-30
   PubMed Web of Science ®Google Scholar
• Mössner R, Daniel S, Albert D, et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000;36(3):197-202
   PubMed Web of Science ®Google Scholar
• Goggi J, Pullar IA, Carney SL, et al. Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro. Brain Res 2002;941(1):34-42
   PubMed Web of Science ®Google Scholar
• Lang SB, Stein V, Bonhoeffer T, et al. Endogenous brain-derived neurotrophic factor triggers fast calcium transients at synapses in developing dendrites. J Neurosci 2007;27(5):1097-105
   PubMed Web of Science ®Google Scholar
• Molteni R, Cattaneo A, Calabrese F, et al. Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. Neurobiol Dis 2010;37(3):747-55
   PubMed Web of Science ®Google Scholar
• Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 2010;64(4):341-57
   PubMed Web of Science ®Google Scholar
• Koob GF. Addiction is a reward deficit and stress surfeit disorder. Front Psychiatry 2013;4:72
   PubMedGoogle Scholar
• Guidotti G, Calabrese F, Auletta F, et al. Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment. Neuropsychopharmacology 2012;37(3):746-58
   PubMed Web of Science ®Google Scholar
• Zetterström T, Pei Q, Madhav T, et al. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 1999;38(7):1063-73
   PubMed Web of Science ®Google Scholar
• Vaidya VA, Marek GJ, Aghajanian GK, et al. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 1997;17(8):2785-95
   PubMed Web of Science ®Google Scholar
• Nic Dhonnchadha B, Fox R, Stutz S, et al. Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci 2009;123(2):382
   PubMed Web of Science ®Google Scholar
• Grottick AJ, Fletcher PJ, Higgins GA. Studies to investigate the role of 5-HT2C receptors on cocaine-and food-maintained behavior. J Pharmacol Exp Ther 2000;295(3):1183-91
   PubMed Web of Science ®Google Scholar
• Pascual-Brazo J, Castro E, Diaz A, et al. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT(4) receptor agonist RS67333. Int J Neuropsychopharmacol 2012;15(5):631-43
   PubMed Web of Science ®Google Scholar
• Pilar Cuéllar F, Vidal R, Pazos A. Subchronic treatment with fluoxetine and ketanserin increases hippocampal. brain-derived neurotrophic factor, beta-catenin and antidepressant-like effects. Br J Pharmacol 2012;165(4b):1046-57
   PubMed Web of Science ®Google Scholar
• Siuciak JA, Boylan C, Fritsche M, et al. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 1996;710(1):11-20
   PubMed Web of Science ®Google Scholar
• Li B, Arime Y, Hall FS, et al. Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice. Eur J Pharmacol 2010;628(1):104-7
   PubMed Web of Science ®Google Scholar
• Broos N, Loonstra R, Mourik Y, et al. Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making. Addict Biol 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Schroeder JP, Epps SA, Grice TW, et al. The selective dopamine beta-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior. Neuropsychopharmacology 2013;38(6):1032-8
   PubMed Web of Science ®Google Scholar
• Chen M, Nguyen T, Pike C, et al. Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cell Signal 2007;19(1):114-28
   PubMed Web of Science ®Google Scholar
• Peterson AB, Abel JM, Lynch WJ. Dose-dependent effects of wheel running on cocaine-seeking and prefrontal cortex Bdnf exon IV expression in rats. Psychopharmacology (Berl) 2014;231(7):1305-14
   PubMed Web of Science ®Google Scholar
• Sadri-Vakili G, Kumaresan V, Schmidt HD, et al. Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci 2010;30(35):11735-44
   PubMed Web of Science ®Google Scholar
• Cassel S, Carouge D, Gensburger C, et al. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 2006;70(2):487-92
   PubMed Web of Science ®Google Scholar
• Pollack MH, Rosenbaum JF. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 1991;52(1):31-3
   PubMed Web of Science ®Google Scholar
• Grabowski J, Rhoades H, Elk R, et al. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled, double-blind trials. J Clin Psychopharmacol 1995;15(3):163-74
   PubMed Web of Science ®Google Scholar
• Bulling S, Schicker K, Zhang Y, et al. The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem 2012;287(22):18524
   PubMed Web of Science ®Google Scholar
• Cappendijk SL, Dzoljic MR. Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur J Pharmacol 1993;241(2):261-5
   PubMed Web of Science ®Google Scholar
• Alper KR, Lotsof HS, Frenken G, et al. Treatment of acute opioid withdrawal with ibogaine. Am J Addict 1999;8(3):234-42
   PubMed Web of Science ®Google Scholar
• Cunningham KA, Anastasio NC, Fox RG, et al. Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction. ACS Chem Neurosci 2012;4(1):110-21
   PubMed Web of Science ®Google Scholar
• Manvich DF, Kimmel HL, Cooper DA, et al. The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys. J Pharmacol Exp Ther 2012;342(3):761-9
   PubMed Web of Science ®Google Scholar
• Manvich DF, Kimmel HL, Howell LL. Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 2012;341(2):424-34
   PubMed Web of Science ®Google Scholar
• Murnane KS, Winschel J, Schmidt KT, et al. Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates. J Neurosci 2013;33(33):13367-74
   PubMed Web of Science ®Google Scholar
• Valjent E, Hervé D, Girault JA, et al. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 2004;19(7):1826-36
   PubMed Web of Science ®Google Scholar
• Valjent E, Corbillé AG, Bertran-Gonzalez J, et al. Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci USA 2006;103(8):2932-7
   PubMed Web of Science ®Google Scholar
• Corominas M, Roncero C, Ribases M, et al. Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction. Neuropsychobiology 2007;55(1):2-13
   PubMed Web of Science ®Google Scholar
• Izzo E, Martin-Fardon R, Koob GF, et al. Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nat Neurosci 2002;5(12):1263-4
   PubMed Web of Science ®Google Scholar
• Zhang X, Mi J, Wetsel WC, et al. PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity. Biochem Biophys Res Commun 2006;340(4):1144-50
   PubMed Web of Science ®Google Scholar
• Self DW, Genova LM, Hope BT, et al. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 1998;18(5):1848-59
   PubMed Web of Science ®Google Scholar
• Cazorla M, Jouvenceau A, Rose C, et al. Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice. PLoS One 2010;5(3):e9777
   PubMed Web of Science ®Google Scholar
• Itzhak Y, Liddie S, Anderson KL. Sodium butyrate-induced histone acetylation strengthens the expression of cocaine-associated contextual memory. Neurobiol Learn Mem 2013;102:34-42
   PubMed Web of Science ®Google Scholar
• Raybuck JD, McCleery EJ, Cunningham CL, et al. The histone deacetylase inhibitor sodium butyrate modulates acquisition and extinction of cocaine-induced conditioned place preference. Pharmacol Biochem Behav 2013;106:109-16
   PubMed Web of Science ®Google Scholar
• Sun J, Wang L, Jiang B, et al. The effects of sodium butyrate, an inhibitor of histone deacetylase, on the cocaine-and sucrose-maintained self-administration in rats. Neurosci Lett 2008;441(1):72-6
   PubMed Web of Science ®Google Scholar
• Malvaez M, McQuown SC, Rogge GA, et al. HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc Natl Acad Sci USA 2013;110(7):2647-52
   PubMed Web of Science ®Google Scholar
• Romieu P, Host L, Gobaille S, et al. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 2008;28(38):9342-8
   PubMed Web of Science ®Google Scholar